We are live on ! Find out more

Roundhill GLP-1 & Weight Loss ETF

OZEM

Market cap $55.9M

30.57 USD

-0.13

0.42%

At close Updated Nov 2, 4:00 PM EST

1 day

-0.42%

5 days

3.8%

1 month

2.14%

3 months

-3.56%

6 months

-2.46%

Year to date

-10.98%

1 year

5.34%

5 years

20.5%

10 years

20.5%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 100%

Neutral 0%

Negative 0%

Zacks Investment Research

Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss

Novo Nordisk's CagriSema delivers 25% weight loss in women, spotlighting three ETFs for diversified exposure to the sector's growth.

Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss

Zacks Investment Research

Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market

REX Shares recently launched the REX Peptide ETF (PEPT), a thematic fund offering global exposure to the peptide industry, from drug developers to manufacturers and delivery platforms.

Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market

From Laggard to Leader: The Surprising Comeback of Healthcare

Healthcare stocks have finally stepped back into the spotlight. After spending much of the past several years in the shadow of technology and AI, the sector has quietly emerged as one of the year's more compelling comeback stories.

From Laggard to Leader: The Surprising Comeback of Healthcare

Zacks Investment Research

Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win

LLY and Novo face off at EASD as new data fuels the GLP-1 market, while ETFs offer diversified exposure to weight loss drug growth.

Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win

Zacks Investment Research

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sectors, supported by relatively steady demand regardless of the economic environment.

Healthcare ETFs: From Broad Exposure to Big Breakthroughs

Zacks Investment Research

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

Zacks Investment Research

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

3 Ways to Invest in the Growing GLP-1 Weight Loss Market

Weight loss drugs are big business, with the GLP-1 receptor agonist market expected to nearly triple in size to $185 billion by 2033, a compound annual growth rate of about 12.4%. Although increasingly a global medical phenomenon, the bulk of the market still exists in the United States, and domestic investors can get in on the action by targeting companies that manufacture these powerful drugs.

3 Ways to Invest in the Growing GLP-1 Weight Loss Market

Oral GLP-1 Is Here - Have Credit Markets Caught Up?

For the past two years, GLP-1 medications have been a fixture of consumer trend analysis, discussed by everyone from CNBC to sell-side strategists to management consultants. Real apparel expenditure outperformed total consumer spending by approximately 400 basis points per month on average in 2025, a trend our analysis attributes in part to GLP-1-driven wardrobe replacement. The oral pill launch likely means the population of GLP-1 users will grow materially over the next several years.

Oral GLP-1 Is Here - Have Credit Markets Caught Up?

See News Rankings

Price charts implemented using Lightweight Charts™